CRISIL Revises Neogen Chemicals' Rating Outlook to Stable Post ₹600 Crore QIP
Neogen Chemicals Ltd · Others (Uncategorized) · 27 Sept 2026, 12:42 am
CRISIL Revises Neogen Chemicals' Rating Outlook to Stable Post ₹600 Crore QIP On 26th Sep'26, CRISIL Ratings reaffirmed Neogen Chemicals Limited's long-term bank facilities (₹680 crore) and NCDs (₹200 crore) at 'CRISIL A-', while revising the outlook to 'Stable' from 'Negative', and reaffirmed its short-term rating at 'CRISIL A2+'. Wholly owned subsidiary Neogen Ionics' ₹1,150 crore bank facilities were reaffirmed at 'CRISIL BBB+/Stable'. The outlook revision reflects a strengthened financial risk profile following a ₹600 crore QIP aimed at debt reduction, post-fire operational stabilization, and key capex commissioning to drive medium-term growth.
Original exchange filing (PDF)
More announcements from Neogen Chemicals Ltd
- Earnings Call Transcript - Q2FY2027. · 09 Nov 2026
- Update on Fire Incident - Order for Revocation of earlier Directions issued by GPCB and granting of CC&A Amendment by GPCB. · 08 Nov 2026
- Update on Fire Incident- Order for Revocation of earlier Directions issued by GPCB and granting of of CC&A Amendment by GPCB. · 08 Nov 2026
- Disclosure pursuant to Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 ("PIT Regulations") · 08 Nov 2026
- Notice of Postal Ballot · 07 Nov 2026
- Intimation of Analyst/Investor Meeting to be held on November 17, 2026. · 04 Nov 2026
- Monitoring agency report for the quarter ended September 30, 2026 i.r.o. QIP of Rs. 600 crores. · 03 Nov 2026
- Earnings call recording Q2 H1 FY 2027 · 03 Nov 2026
